|
ProGEM™ - Biomarker Diagnostic for Targeted Therapy
The use of molecular biomarkers in the diagnosis and treatment of disease has become an important facet of modern drug development. Biomarker-based diagnostic products are frequently used beyond initial diagnosis to select patients for specific therapies and monitor disease response to the therapy. ProGEM is a proprietary diagnostic product based upon a key molecular biomarker, under development for use initially in oncology. ProGEM is currently in mid stage development.
|
